Official Committee of Opioid Related Claimants of Mallinckrodt plc and its affiliated debtors

Case No. 20-12522

The Chapter 11 Cases

On October 12, 2020 (the “Petition Date”), Mallinckrodt plc, substantially all of its U.S. subsidiaries, including its Specialty Brands and Specialty Generics entities, and certain of its international subsidiaries, (collectively, “Mallinckrodt” or the “Debtors”) voluntarily initiated proceedings under chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware (the “Court”).  Mallinckrodt’s cases have been assigned to the Honorable John T. Dorsey, and are jointly administered under Case No. 20-12522.  The case docket can be accessed at the link on the left or through the website maintained by the Court.

The Opioid Claimants Committee

On October 27, 2020, the United States Trustee for Region 3 (the “U.S. Trustee”) appointed seven creditors to serve on the Official Committee of Opioid Related Creditors (the “OCC”) and represent the interests of all of the Debtors’ opioid-related creditors (collectively, “Opioid Claimants”).  See Notice of Appointment of Opioid Related Claimants Committee [ECF No. 308].

Opioid Claimants may direct any inquiries regarding these proceedings to:

You may also call the telephone number listed in the "Info Center" box to the right.

Contact information for the OCC's proposed advisors is available at the bottom of this page. 

Important Information & Dates

Please click here for a detailed case calendar that includes significant dates and deadlines.

At this time, the Debtors have not established a bar date for opioid-related claims.  Thus, if your claim is based on direct or indirect exposure to the Debtors’ opioid products or the Debtors’ role in perpetuating the opioid crisis, you are not required to file a proof of claim at this time.

The OCC believes that a bar date and noticing program for Opioid Claimants should be established in these cases, and, therefore, the OCC filed a motion seeking to compel to the Debtors to establish an Opioid Claimant bar date and corresponding noticing program.  Absent consensual resolution of the issue with the Debtors, the OCC’s motion to establish a bar date for Opioid Claimants is scheduled to be heard by the Bankruptcy Court on or about February 28, 2021, or on such later date as the parties may agree.  


The Court has established bar dates for filing claims other than opioid claims.  Information regarding claims that are subject to such bar dates may be found in the Bar Date Notice and the Bar Date Order.  

The Debtors filed their Schedules of Assets and Liabilities and Statements of Financial Affairs on December 23, 2020.

Section 341 Meeting of Creditors

In accordance with Section 341 of the Bankruptcy Code, meetings of the Debtors’ creditors were held on Thursday, November 19, 2020 at 10:00 a.m. (ET), Monday, February 1, 2021 at 10:00 a.m. (ET) and Friday, February 12, 2021 at 10:00 a.m. (ET).

Additional Case Background

On the Petition Date, Mallinckrodt announced that it had entered into several key agreements that, if approved by the Court in connection with a plan of reorganization, would resolve a range of Mallinckrodt's legal liabilities. Such agreements include:

  • A restructuring support agreement with key creditors and litigation parties outlining the terms of a financial restructuring designed to strengthen Mallinckrodt’s balance sheet and reduce its debt by approximately $1.3 billion;
  • An agreement in principle with certain governmental opioid litigation claimants on a proposed opioid settlement that would resolve opioid-related claims against Mallinckrodt and its subsidiaries; and
  • An agreement in principle with the certain governmental parties to resolve various Acthar® Gel related matters, including the CMS Medicaid rebate dispute.

The U.S. Trustee has also appointed an official committee of unsecured creditors (the “UCC”), which represents the interests of Mallinckrodt’s unsecured creditors other than Opioid Claimants.  See Notice of Appointment of Committee of Unsecured Creditors [ECF No. 306].  If you are an unsecured creditor of Mallinckrodt with a non-opioid related claim, please direct any questions or inquiries regarding these proceedings to the advisors to the UCC. 


April 27 2021 Omnibus Hearing 10:00 a.m. (ET) Order Scheduli... Add to Calendar
May 12 2021 Omnibus Hearing 3:00 p.m. (ET)   Add to Calendar
May 26 2021 Omnibus Hearing 1:00 p.m. (ET) ACTHAR PLAINTI... Add to Calendar
October 12 2020 ----
November 19 2020 10:00
November 23 2020 2:00 p.m. (ET)
December 7 2020 10:00 a.m. (ET)
December 14 2020 1:00 a.m. (ET)
December 14 2020 1:00 p.m. (ET)
December 22 2020 10:00 a.m. (ET)
December 24 2020 ---
January 14 2021 2:00 p.m. (ET)
January 28 2021 2:00 p.m. (ET)
February 3 2021 11:00 a.m. (ET)
February 11 2021 11:00 a.m. (ET)
February 12 2021 10:00 a.m. (ET)
Section 341 Meeting of Creditors Add to Calendar
February 25 2021 2:00 p.m. (ET)
March 10 2021 2:00 p.m. (ET)
March 16 2021 11:00 a.m. (ET)
March 30 2021 2:00 p.m. (ET)
March 31 2021 3:00 p.m. (ET)
April 13 2021 11:00 a.m. (ET)
April 27 2021 10:00 a.m. (ET)
May 12 2021 3:00 p.m. (ET)
Omnibus Hearing Add to Calendar
May 26 2021 1:00 p.m. (ET)


Advisors to the Official Committee of Opioid Related Claimants

  • Lead Counsel

    Akin Gump Strauss Hauer & Feld LLP
    One Bryant Park
    New York, NY   10036
    Phone: 212.872.1000
    Fax: 212-872.1002

    Arik Preis
    Mitchell P. Hurley
    Sara L. Brauner
    Edan Lisovicz

  • Delaware & Efficiency Counsel

    Cole Schotz, P.C.
    500 Delaware Avenue, Suite 1410
    Wilmington, DE   19801
    Phone: 302.655.5000
    Fax: 302.658.6395

    Justin R. Alberto, Esq.

  • Financial Advisor

    Province, Inc.
    36 S. Charles St. Suite 2310
    Baltimore, MD   21201
    Phone: 702.685.5555

    Michael Atkinson

  • Investment Banker

    Jefferies LLC
    520 Madison Avenue
    New York, NY   10022

    Leon Szlezinger

  • Canadian Counsel

    Cassels Brock & Blackwell LLP
    Suite 2100, Scotia Plaza, 40 King St. W.
    Toronto, ON M5H 3C2   Canada

    Natalie E. Levine